131 related articles for article (PubMed ID: 1663593)
1. Trimipramine: pharmacological reevaluation and comparison with clozapine.
Gross G; Xin X; Gastpar M
Neuropharmacology; 1991 Nov; 30(11):1159-66. PubMed ID: 1663593
[TBL] [Abstract][Full Text] [Related]
2. Effect of long-term administration of antidepressant drugs on the 5-HT3 receptors that enhance the electrically evoked release of [3H]noradrenaline in the rat hippocampus.
Mongeau R; De Montigny C; Blier P
Eur J Pharmacol; 1994 Dec; 271(1):121-9. PubMed ID: 7698195
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of noradrenaline release from rat cerebral cortex by neuroleptic drugs.
Gross G; Schümann HJ
Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(2):103-9. PubMed ID: 6111028
[TBL] [Abstract][Full Text] [Related]
4. Biochemical profile of risperidone, a new antipsychotic.
Leysen JE; Gommeren W; Eens A; de Chaffoy de Courcelles D; Stoof JC; Janssen PA
J Pharmacol Exp Ther; 1988 Nov; 247(2):661-70. PubMed ID: 2460616
[TBL] [Abstract][Full Text] [Related]
5. The modulation of [3H]noradrenaline and [3H]serotonin release from rat brain synaptosomes is not mediated by the alpha 2B-adrenoceptor subtype.
Gobbi M; Frittoli E; Mennini T
Naunyn Schmiedebergs Arch Pharmacol; 1990 Oct; 342(4):382-6. PubMed ID: 1979424
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological evaluation of 1-[(1,2-diphenyl-1H-4-imidazolyl)methyl]-4-phenylpiperazines with clozapine-like mixed activities at dopamine D(2), serotonin, and GABA(A) receptors.
Asproni B; Pau A; Bitti M; Melosu M; Cerri R; Dazzi L; Seu E; Maciocco E; Sanna E; Busonero F; Talani G; Pusceddu L; Altomare C; Trapani G; Biggio G
J Med Chem; 2002 Oct; 45(21):4655-68. PubMed ID: 12361392
[TBL] [Abstract][Full Text] [Related]
7. Involvement of adenylate cyclase and protein kinase C in the alpha 2-adrenoceptor-mediated inhibition of noradrenaline and 5-hydroxytryptamine release in rat hypothalamic slices.
Ramdine R; Galzin AM; Langer SZ
Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):386-95. PubMed ID: 2479843
[TBL] [Abstract][Full Text] [Related]
8. The importance of serotonin-dopamine interactions in the action of clozapine.
Meltzer HY
Br J Psychiatry Suppl; 1992 May; (17):22-9. PubMed ID: 1358125
[TBL] [Abstract][Full Text] [Related]
9. Effects of the putative P-type calcium channel blocker, R,R-(-)-daurisoline on neurotransmitter release.
Waldmeier PC; Wicki P; Fröstl W; Bittiger H; Feldtrauer JJ; Baumann PA
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):670-8. PubMed ID: 9053740
[TBL] [Abstract][Full Text] [Related]
10. The role of 5-HT1A autoreceptors and alpha1-adrenoceptors in the modulation of 5-HT release--III. Clozapine and the novel putative antipsychotic S 16924.
Bengtsson HJ; Kullberg A; Millan MJ; Hjorth S
Neuropharmacology; 1998; 37(3):349-56. PubMed ID: 9681933
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of noradrenaline release via presynaptic 5-HT1D alpha receptors in human atrium.
Molderings GJ; Frölich D; Likungu J; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):272-80. PubMed ID: 8692281
[TBL] [Abstract][Full Text] [Related]
12. The effects of chronic trimipramine treatment on biogenic amine metabolism and on dopamine D2, 5-HT2 and tryptamine binding sites in rat brain.
Juorio AV; Li XM; Boulton AA
Gen Pharmacol; 1990; 21(5):759-62. PubMed ID: 2177438
[TBL] [Abstract][Full Text] [Related]
13. Extended radioligand binding profile of iloperidone: a broad spectrum dopamine/serotonin/norepinephrine receptor antagonist for the management of psychotic disorders.
Kalkman HO; Subramanian N; Hoyer D
Neuropsychopharmacology; 2001 Dec; 25(6):904-14. PubMed ID: 11750183
[TBL] [Abstract][Full Text] [Related]
14. 5-HT1 and 5-HT2 binding profiles of the serotonergic agents alpha-methylserotonin and 2-methylserotonin.
Ismaiel AM; Titeler M; Miller KJ; Smith TS; Glennon RA
J Med Chem; 1990 Feb; 33(2):755-8. PubMed ID: 2299641
[TBL] [Abstract][Full Text] [Related]
15. In vivo receptor occupancy of NRA0045, a putative atypical antipsychotic, in rats.
Chaki S; Funakoshi T; Yoshikawa R; Okuyama S; Kumagai T; Nakazato A; Nagamine M; Tomisawa K
Neuropharmacology; 1999 Aug; 38(8):1185-94. PubMed ID: 10462131
[TBL] [Abstract][Full Text] [Related]
16. Effect of antidepressant and neuroleptic drugs on the electrically evoked release of serotonin from rat cerebral cortex.
Gross G; Hante K; Göthert M
Psychopharmacology (Berl); 1987; 91(2):175-81. PubMed ID: 2883696
[TBL] [Abstract][Full Text] [Related]
17. Phenylethylamine-induced release of noradrenaline fails to stimulate alpha 1-adrenoceptors modulating [3H]-acetylcholine release in rat atria, but activates alpha 2-adrenoceptors modulating [3H]-serotonin release in the hippocampus.
Benkirane S; Arbilla S; Langer SZ
Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):149-55. PubMed ID: 3024030
[TBL] [Abstract][Full Text] [Related]
18. Activation of 5-HT3 receptors enhances the electrically evoked release of [3H]noradrenaline in rat brain limbic structures.
Mongeau R; De Montigny C; Blier P
Eur J Pharmacol; 1994 May; 256(3):269-79. PubMed ID: 8045271
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties.
Oka M; Noda Y; Ochi Y; Furukawa K; Une T; Kurumiya S; Hino K; Karasawa T
J Pharmacol Exp Ther; 1993 Jan; 264(1):158-65. PubMed ID: 8093723
[TBL] [Abstract][Full Text] [Related]
20. Further studies on alpha 2-adrenoceptor subtypes involved in the modulation of [3H]noradrenaline and [3H]5-hydroxytryptamine release from rat brain cortex synaptosomes.
Gobbi M; Frittoli E; Mennini T
J Pharm Pharmacol; 1993 Sep; 45(9):811-4. PubMed ID: 7903370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
